Auto hematopoietic cell transplant not beneficial for mantle cell lymphoma with undetectable residual disease

by Elana GotkineAutologous hematopoietic cell transplant (auto-HCT) is not beneficial for patients with mantle cell lymphoma (MCL) in first complete remission (CR) with undetectable minimal residual d

Updated on: December 21,2024

Auto hematopoietic cell transplant not beneficial for mantle cell lymphoma with undetectable residual disease

by Elana GotkineAutologous hematopoietic cell transplant (auto-HCT) is not beneficial for patients with mantle cell lymphoma (MCL) in first complete remission (CR) with undetectable minimal residual d

Updated on:December 21,2024

New toolkit to support the collection of cancer-patient-reported outcome measures

byUniversity of Strathclyde, GlasgowCredit: Pixabay/CC0 Public DomainA new Scotland-wide toolkit is supporting the collection of patient-reported outcome measures (PROMs) to understand the impac

Updated on: December 19,2024

New toolkit to support the collection of cancer-patient-reported outcome measures

byUniversity of Strathclyde, GlasgowCredit: Pixabay/CC0 Public DomainA new Scotland-wide toolkit is supporting the collection of patient-reported outcome measures (PROMs) to understand the impac

Updated on:December 19,2024

Researchers design novel immunotherapy for brain cancer

byThe Wistar InstituteCredit: Unsplash/CC0 Public DomainThe Wistar Institute's David B. Weiner, Ph.D.—Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Sm

Updated on: December 20,2024

Researchers design novel immunotherapy for brain cancer

byThe Wistar InstituteCredit: Unsplash/CC0 Public DomainThe Wistar Institute's David B. Weiner, Ph.D.—Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Sm

Updated on:December 20,2024

Co-located cell types help drive aggressive brain tumors, study finds

Updated on: March 27,2025

Co-located cell types help drive aggressive brain tumors, study finds

Updated on:March 27,2025

Colorectal cancer risk factors important to consider for rescreening interval

by Lori SolomonColorectal cancer (CRC) risk factors are important to consider when making decisions for colonoscopy rescreening following negative colonoscopy screening (NCS) results (no presence of C

Updated on: December 21,2024

Colorectal cancer risk factors important to consider for rescreening interval

by Lori SolomonColorectal cancer (CRC) risk factors are important to consider when making decisions for colonoscopy rescreening following negative colonoscopy screening (NCS) results (no presence of C

Updated on:December 21,2024

Cancer's ripple effect may promote blood clot formation in the lungs

Updated on: March 27,2025

Cancer's ripple effect may promote blood clot formation in the lungs

Updated on:March 27,2025

Patients with MAFLD have 4.7 times higher risk of developing liver cancer, study finds

by Korea University College of MedicineEvolutionary changes in MASLD are associated with differential risks of hepatocellular carcinoma. Credit: Korea University MedicineResearch has revealed that in

Updated on: December 20,2024

Patients with MAFLD have 4.7 times higher risk of developing liver cancer, study finds

by Korea University College of MedicineEvolutionary changes in MASLD are associated with differential risks of hepatocellular carcinoma. Credit: Korea University MedicineResearch has revealed that in

Updated on:December 20,2024

Researchers explore e-bikes for cancer recovery

by Patty Wellborn,University of British ColumbiaOutline of the CRANK intervention development. APEASE: Acceptability, Practicability, Effectiveness, Affordability, Side-Effects, and Equity; BCT:

Updated on: December 20,2024

Researchers explore e-bikes for cancer recovery

by Patty Wellborn,University of British ColumbiaOutline of the CRANK intervention development. APEASE: Acceptability, Practicability, Effectiveness, Affordability, Side-Effects, and Equity; BCT:

Updated on:December 20,2024

Overcoming glioblastoma resistance to chemotherapy

byInstitute for Basic ScienceThe "onion model" illustrates how the one-by-one inactivation of the DNA repair pathways brings about changes in TMZ-induced mutational signatures. Every &

Updated on: January 23,2025

Overcoming glioblastoma resistance to chemotherapy

byInstitute for Basic ScienceThe "onion model" illustrates how the one-by-one inactivation of the DNA repair pathways brings about changes in TMZ-induced mutational signatures. Every &

Updated on:January 23,2025

Prior authorization delays lead to serious harm for people with cancer, nationwide survey finds

byAmerican Society for Radiation OncologyCredit: American Society for Radiation OncologyA new nationwide survey of more than 750 radiation oncologists confirms that prior authorization harms peo

Updated on: December 19,2024

Prior authorization delays lead to serious harm for people with cancer, nationwide survey finds

byAmerican Society for Radiation OncologyCredit: American Society for Radiation OncologyA new nationwide survey of more than 750 radiation oncologists confirms that prior authorization harms peo

Updated on:December 19,2024

Even low levels of arsenic in drinking water raise kidney cancer risk, new study finds

by Ann Kellett,Texas A&M UniversityCredit: Unsplash/CC0 Public DomainNew research findings from the Texas A&M University School of Public Health indicate that exposure to even low levels

Updated on: December 20,2024

Even low levels of arsenic in drinking water raise kidney cancer risk, new study finds

by Ann Kellett,Texas A&M UniversityCredit: Unsplash/CC0 Public DomainNew research findings from the Texas A&M University School of Public Health indicate that exposure to even low levels

Updated on:December 20,2024

Clinical trial tests new drug to reduce side effect of 'half-matched' stem cell transplants

by Julia Evangelou Strait,Washington University School of MedicineCredit: CC0 Public DomainAdding a new drug to standard care for stem cell transplant recipients may reduce a life-threatening si

Updated on: December 20,2024

Clinical trial tests new drug to reduce side effect of 'half-matched' stem cell transplants

by Julia Evangelou Strait,Washington University School of MedicineCredit: CC0 Public DomainAdding a new drug to standard care for stem cell transplant recipients may reduce a life-threatening si

Updated on:December 20,2024